NXGN-M logo

Nextgen Biomed Ltd Stock Price

TASE:NXGN-M Community·₪6.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

NXGN-M Share Price Performance

₪0.41
-0.16 (-27.51%)
₪0.41
-0.16 (-27.51%)
Price ₪0.41

NXGN-M Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with weak fundamentals.

6 Risks
0 Rewards

Nextgen Biomed Ltd Key Details

₪0

Revenue

₪0

Cost of Revenue

₪0

Gross Profit

₪9.5m

Other Expenses

-₪9.5m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.65
0%
0%
-27.5%
View Full Analysis

About NXGN-M

Founded
1990
Employees
3
CEO
Harel Hershtik
WebsiteView website
www.nextgen-biomed.com

Nextgen Biomed Ltd engages in research and development activities. It provides EyePen, a smart and modular device that consists of insulin injection pens and assists users in self-managing the diabetes treatment by recording the times and doses of insulin taken via injection it includes a camera, a voice-based monitoring system, a bluetooth component, a real-time image processor, connectivity and tracking of insulin injections using a dedicated mobile/computer/cloud application, based on AI that allows it to collect and manage information. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Rehovot, Israel.

Recent NXGN-M News & Updates

Recent updates

No updates